163 related articles for article (PubMed ID: 36340281)
1. Constructing agri-food for finance: startups, venture capital and food future imaginaries.
Sippel SR; Dolinga M
Agric Human Values; 2023; 40(2):475-488. PubMed ID: 36340281
[TBL] [Abstract][Full Text] [Related]
2. Tackling land's 'stubborn materiality': the interplay of imaginaries, data and digital technologies within farmland assetization.
Sippel SR
Agric Human Values; 2023 May; ():1-15. PubMed ID: 37359848
[TBL] [Abstract][Full Text] [Related]
3. The project, the everyday, and reflexivity in sociotechnical agri-food assemblages: proposing a conceptual model of digitalisation.
Forney J; Dwiartama A
Agric Human Values; 2023; 40(2):441-454. PubMed ID: 37287886
[TBL] [Abstract][Full Text] [Related]
4. Is Digital Health for Diabetes in an Investment Bubble?
Klonoff DC; Evans B; Zweig M; Day S; Kerr D
J Diabetes Sci Technol; 2020 Jan; 14(1):165-169. PubMed ID: 31470739
[TBL] [Abstract][Full Text] [Related]
5. Venture Capital Investment in the Life Sciences in Switzerland.
Hosang M
Chimia (Aarau); 2014 Dec; 68(12):847-9. PubMed ID: 26508600
[TBL] [Abstract][Full Text] [Related]
6. Does digital finance improve the green investment of Chinese listed heavily polluting companies? The perspective of corporate financialization.
Jiang Y; Guo C; Wu Y
Environ Sci Pollut Res Int; 2022 Oct; 29(47):71047-71063. PubMed ID: 35595899
[TBL] [Abstract][Full Text] [Related]
7. How venture capital works.
Zider B
Harv Bus Rev; 1998; 76(6):131-9. PubMed ID: 10187243
[TBL] [Abstract][Full Text] [Related]
8. Role of Venture Capital in Enterprise Innovation Under Psychological Capital and Heterogeneity of Entrepreneur Capital.
Zhang C; Mao D; Wang M
Front Psychol; 2020; 11():1704. PubMed ID: 32754105
[TBL] [Abstract][Full Text] [Related]
9. Venture funding for science-based African health innovation.
Masum H; Chakma J; Simiyu K; Ronoh W; Daar AS; Singer PA
BMC Int Health Hum Rights; 2010 Dec; 10 Suppl 1(Suppl 1):S12. PubMed ID: 21144072
[TBL] [Abstract][Full Text] [Related]
10. Venture Capital Investment in Orthopaedics: Has the Landscape Changed over the Past Two Decades (2000-2019)?
Cwalina TB; Jella TK; Acuña AJ; Samuel LT; Kamath AF
Surg Innov; 2022 Feb; 29(1):103-110. PubMed ID: 34243691
[No Abstract] [Full Text] [Related]
11. Sociotechnical imaginaries of low-carbon waste-energy futures: UK techno-market fixes displacing public accountability.
Levidow L; Raman S
Soc Stud Sci; 2020 Aug; 50(4):609-641. PubMed ID: 32077372
[TBL] [Abstract][Full Text] [Related]
12. Startups learn from hospital investors.
Barkholz D
Mod Healthc; 2017 Mar; 47(11):30. PubMed ID: 30408400
[TBL] [Abstract][Full Text] [Related]
13. The Internal Connection Analysis of Information Sharing and Investment Performance in the Venture Capital Network Community.
Feng B; Sun K; Zhong Z; Chen M
Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831699
[TBL] [Abstract][Full Text] [Related]
14. Commercializing biomedical research through securitization techniques.
Fernandez JM; Stein RM; Lo AW
Nat Biotechnol; 2012 Oct; 30(10):964-75. PubMed ID: 23023199
[TBL] [Abstract][Full Text] [Related]
15. From atoms to bits: Resource mobilization of non-digital, hybrid, and digital cleantech startups.
Kurowski S
Heliyon; 2024 Jan; 10(1):e23697. PubMed ID: 38192773
[TBL] [Abstract][Full Text] [Related]
16. The role of financial markets in the energy transition: an analysis of investment trends and opportunities in renewable energy and clean technology.
Li B
Environ Sci Pollut Res Int; 2023 Sep; 30(43):97948-97964. PubMed ID: 37599346
[TBL] [Abstract][Full Text] [Related]
17. Finance's Social License? Sugar, Farmland and Health.
Smith K; Lawrence G
Int J Health Policy Manag; 2021 Dec; 10(12):957-967. PubMed ID: 33904701
[TBL] [Abstract][Full Text] [Related]
18. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
[TBL] [Abstract][Full Text] [Related]
19. [STATE-OF-THE-ART OF GLOBAL START-UP INVESTMENT FOR ALLERGY AND IMMUNOLOGY 2022].
Adachi T; Hayano M; Ito Y; Inomata T; Ogawa Y; Kainuma K; Kan-O K; Kurashima Y; Kuwabara Y; Sakashita M; Sato S; Tomita Y; Nakajima S; Futamura M; Masaki K; Tamari M; Ebisawa M; Morita H
Arerugi; 2024; 73(3):268-278. PubMed ID: 38749711
[TBL] [Abstract][Full Text] [Related]
20. The decline of venture capital investment in early-stage life sciences poses a challenge to continued innovation.
Fleming JJ
Health Aff (Millwood); 2015 Feb; 34(2):271-6. PubMed ID: 25646107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
